II Update Course in Genetic Epilepsies and Precision Medicine in Spanish
PROGRAM (in English)
Lectures in Spanish time: UTC/GMT +1
First day
15:30 – 15:40
Presentation of the course. Antonio Gil-Nagel, Hospital Ruber Internacional, Madrid.
15:40 – 17:20
Diagnosis: current situation and immediate future. Moderator: Álvaro Beltrán-Corbellini, Hospital Ruber Internacional, Madrid.
• 15:40-16:00 Indications and types of genetic studies in epilepsy. Álvaro Beltrán-Corbellini, Hospital Ruber Internacional, Madrid.
• 16:00-16:20 Reinterpretation of variants of uncertain significance and non-informative studies in the exome. María Calvo, Blueprint Genetics, Madrid.
• 16:20-16:40 The study of the whole genome in patients with epilepsy. Pablo Lapunzina, Hospital de La Paz y CIBERER, Madrid.
• 16:40-17:00 Polygenic contributions in epilepsy. Eduardo Pérez Palma, Universidad del Desarrollo, Santiago de Chile, Chile.
• 17:00-17:20 Integration of epigenomics and proteomics in the study of patients with epilepsy. Manuel Álvarez Dolado, Laboratorio de Terapia Celular en Neuropatologías, CABIMER, Sevilla.
17:20 – 17:40
Debate – Questions and answers. Moderators: Antonio Gil-Nagel y Álvaro Beltrán-Corbellini.
17:40 – 17:50
Break.
17:50 – 19:30
Clinic 1: current situation and immediate future. Moderator: Antonio Gil-Nagel.
• 17:50-18:10 Classic encephalopathies: West Syndrome and Lennox-Gastaut Syndrome. Antonio Gil-Nagel, Hospital Ruber Internacional, Madrid.
• 18:10-18:30 Dravet Syndrome. Andreas Brunklaus, Royal Hospital for Children, Glasgow, Reino Unido.
• 18:30-18:50 Other sodium channelopathies: SCN2A, SCN8A. Rikke Moller, Danish Epilepsy Center Filadelfia, Dianalund, Dinamarca.
• 18:50-19:10 Potassium channelopathies. Sarah Weckhuysen, VIB Center of Molecular Neurology, Amberes, Bélgica.
• 19:10-19:30 GRINpathies. Susana Boronat, Hospital de la Santa Creu i Sant Pau, Barcelona.
19:30 – 19:50
Debate – Questions and answers. Moderators: Antonio Gil-Nagel y Álvaro Beltrán-Corbellini.
Second day
15:00 – 15:15
Highlights of the first day/Presentation of the 2nd day.Álvaro Beltrán-Corbellini.
15:15 – 17:15
Clinic 2: Current situation and immediate future. Moderator: Irene García Morales, Hospital Ruber Internacional, Madrid.
• 15:15-15:35 Encephalopathy in relation to PCDH19. Paloma Parra Díaz, Hospital Universitario Ramón y Cajal, Madrid.
• 15:35-15:55 CDKL5 deficiency syndrome. Pasquale Striano, Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
• 15:55-16:15 Synaptopathies: STXBP1 and SYNGAP1. Dennis Lal, McGovern Medical School Houston (TX), Epilepsy Center of the Cleveland Clinic (OH), EE.UU.
• 16:15-16:35 Tuberous sclerosis and other mTORpathies. Sara Baldassari, Paris Brain Institute, ICM, Paris, Francia.
• 16:35-16:55 Dup15 and other CNVs in epilepsy. Nicola Specchio, Ospedale Pediatrico Bambino Gesù, Roma, Italia.
16:55 – 17:15
Debate – Questions and answers. Moderators: Antonio Gil-Nagel y Álvaro Beltrán-Corbellini.
17:15 – 17:30
Break.
17:30 – 18:50
Therapeutic approach: current situation and immediate future. Moderator: Rafael Toledano, Hospital Ruber Internacional, Madrid.